Huntington National Bank raised its position in shares of Xylem Inc. (NYSE:XYL) by 21.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,741 shares of the industrial products company’s stock after buying an additional 1,376 shares during the period. Huntington National Bank’s holdings in Xylem were worth $429,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Asset Planning Services Ltd. boosted its stake in Xylem by 0.3% in the first quarter. Asset Planning Services Ltd. now owns 2,107 shares of the industrial products company’s stock worth $106,000 after buying an additional 7 shares during the period. Contravisory Investment Management Inc. boosted its stake in shares of Xylem by 96.1% in the first quarter. Contravisory Investment Management Inc. now owns 2,345 shares of the industrial products company’s stock valued at $118,000 after buying an additional 1,149 shares during the last quarter. Cribstone Capital Management LLC boosted its stake in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock valued at $124,000 after buying an additional 2,247 shares during the last quarter. CENTRAL TRUST Co boosted its stake in shares of Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock valued at $146,000 after buying an additional 1,635 shares during the last quarter. Finally, FNY Partners Fund LP purchased a new stake in shares of Xylem during the first quarter valued at approximately $151,000. Institutional investors and hedge funds own 86.41% of the company’s stock.

Xylem Inc. (NYSE XYL) opened at 60.02 on Monday. The stock has a market cap of $10.78 billion, a P/E ratio of 38.75 and a beta of 1.18. The stock has a 50 day moving average price of $55.49 and a 200-day moving average price of $51.39. Xylem Inc. has a 12-month low of $45.60 and a 12-month high of $60.14.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, August 1st. The industrial products company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.02. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.17 billion. Xylem had a net margin of 7.08% and a return on equity of 16.02%. The company’s revenue was up 24.9% on a year-over-year basis. During the same quarter last year, the business posted $0.48 earnings per share. On average, equities analysts expect that Xylem Inc. will post $2.36 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/07/huntington-national-bank-boosts-stake-in-xylem-inc-xyl-updated.html.

Several analysts recently commented on the company. BMO Capital Markets boosted their price target on Xylem from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. boosted their price objective on Xylem from $60.00 to $66.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 2nd. Royal Bank Of Canada upped their price target on Xylem from $58.00 to $64.00 and gave the company an “outperform” rating in a research note on Wednesday, August 2nd. BidaskClub lowered Xylem from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $50.00 price target on shares of Xylem in a research note on Friday, July 28th. Five analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $58.23.

In related news, Director Steven R. Loranger sold 66,132 shares of the firm’s stock in a transaction that occurred on Thursday, June 29th. The shares were sold at an average price of $55.01, for a total value of $3,637,921.32. Following the completion of the sale, the director now owns 65,030 shares of the company’s stock, valued at $3,577,300.30. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.75% of the company’s stock.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.